COMMUNIQUÉS West-GlobeNewswire

HempAmericana Commences Bottling on Full Spectrum Distillate CBD in Maine Laboratory
13/05/2019
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is pleased to announce that it has commenced bottling 500mg and 1000mg full spectrum CBD [...]
resTORbio to Present RTB101 Phase 2b Clinical Trial Data at American Thoracic Society 2019 International Conference
13/05/2019
BOSTON, May 13, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC) today announced that it will present additional results from the Phase 2b trial evaluating RTB101 (dactolisib), an oral, selective, and potent [...]
WW to Present at Goldman Sachs Global Staples Forum
13/05/2019
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (Nasdaq: WW), a global wellness company and the world’s leading commercial weight management program, today announced that Mindy Grossman, [...]
Neon Therapeutics Reports First Quarter 2019 Financial Results and Provides Clinical Update
13/05/2019
Advancing a class-leading position in neoantigen-based therapies with ongoing progress across its multiple clinical-stage programs, pre-clinical pipeline and bioinformatics engine Expect to report in July top-line [...]
Tonix Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights
13/05/2019
Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD is Enrolling; Topline Data Expected First Half of 2020 NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or [...]
Mustang Bio to Present at the Cell & Gene Therapy USA Congress 2019
13/05/2019
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Retrophin Appoints Sandra E. Poole to Board of Directors
13/05/2019
Ms. Poole brings more than 25 years of biopharmaceutical product development and manufacturing experience to Retrophin SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the [...]
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2019 Financial Results
13/05/2019
REDWOOD CITY, Calif., May 13, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Rafael Pharmaceuticals Appoints Senior Vice President for Clinical Development and Operations
13/05/2019
Newark, NJ, May 13, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced the appointment of Mona M. [...]
Poseida Therapeutics Receives US FDA Orphan Drug Designation for P-BCMA-101 for the Treatment of Multiple Myeloma
13/05/2019
SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, today [...]
111, Inc. to Attend the HSBC 6th Annual China Conference in Shenzhen May 15-17, 2019
13/05/2019
SHANGHAI, China, May 13, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that the Company will participate in the [...]
Exactus One World, LLC. Digs in for Initial Cultivation of 200 Acres in Southwest Oregon
13/05/2019
Cultivating the future of the area and industry, one seedling at a time, bringing CBD from the farm to the family DELRAY BEACH, Fla., May 13, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) (the “Company”), is [...]
Blueberries Receives Approval to Sell Five CBD Wellness Products in Colombia and Internationally from Colombian Food and Drug Regulator
13/05/2019
TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a leading Latin American licensed producer of medicinal cannabis and cannabis- [...]
Arch Therapeutics, Inc. $2.8 Million Registered Direct Offering
13/05/2019
FRAMINGHAM, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH)(“Arch” or the “Company”), a developer of novel liquid, gel and solid hemostatic and wound care devices, today announced the [...]
Aleafia Health Reports First Quarter 2019 Results, Provides Corporate Update
13/05/2019
• Year-Over-Year Revenue Increases by 1,723% • Licence Applications for Niagara Greenhouse, Port Perry Outdoor now Under Review TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: [...]
Metacrine to Present Relevance of FXR and Specific FXR Drug Profiles for Possible Treatment of Inflammatory Bowel Disease at Digestive Disease Week 2019
13/05/2019
SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases, [...]
Kiniksa Presents Clinical and Preclinical Data for KPL-716 at the 77th Annual Meeting of the Society for Investigative Dermatology
13/05/2019
- Data strengthen the scientific evidence for targeting OSMRβ and dual pathway inhibition of IL-31 and OSM via KPL-716 for the potential treatment of chronic pruritic diseases HAMILTON, Bermuda, May 13, 2019 (GLOBE [...]
Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater China
13/05/2019
Onconova to Receive $4 Million Upfront, including $2 Million Fee and $2 Million for Onconova Shares Purchased at a Premium, Plus up to $45.5 Million in Regulatory and Sales Milestones for Rigosertib in Greater China [...]
Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
13/05/2019
Safety study completed; Expect to report data from 2nd pivotal Phase 3 trial by the end of second quarter 2019 NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company [...]

Pages